JPM 2022: With Voxzogo approvals adding up, BioMarin is underway with its ‘biggest launch,’ CEO says
JPM 2022: With Voxzogo approvals adding up, BioMarin is underway [...]
Idorsia makes friends with Jen Aniston for new sleep campaign, as it preps for insomnia drug launch
Idorsia makes friends with Jen Aniston for new sleep campaign, [...]
Biogen compiles buyout target list as Aduhelm woe deepens: Stat
Biogen compiles buyout target list as Aduhelm woe deepens: Stat [...]
Bristol Myers plays it safe with first Zeposia TV ad for ulcerative colitis
Bristol Myers plays it safe with first Zeposia TV ad [...]
CDMO startup INCOG Bio nears completion of injectables plant in Indiana
CDMO startup INCOG Bio nears completion of injectables plant in [...]
Drug repackager Loxha recalls OTC laxative contaminated with microbes
Drug repackager Loxha recalls OTC laxative contaminated with microbes jkeenan [...]
JPM 2022: Novartis rewrites the drug launch playbook with Leqvio, and it doesn’t plan to stop there, exec says
JPM 2022: Novartis rewrites the drug launch playbook with Leqvio, [...]
Performance Cell picked up by private equity firm, rebrands as Cellipont Bioservices
Performance Cell picked up by private equity firm, rebrands as [...]
JPM22, Day 3: Eli Lilly weighs dual branding for diabetes hopeful tirzepatide
JPM22, Day 3: Eli Lilly weighs dual branding for diabetes [...]
For Biogen’s Aduhelm, narrow coverage from CMS ‘could effectively spell the end’: analyst
For Biogen’s Aduhelm, narrow coverage from CMS ‘could effectively spell [...]